Menu
GeneBe

rs17001868

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_015705.6(SGSM3):c.-112+11539A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.126 in 152,176 control chromosomes in the GnomAD database, including 2,018 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.13 ( 2018 hom., cov: 32)

Consequence

SGSM3
NM_015705.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.174
Variant links:
Genes affected
SGSM3 (HGNC:25228): (small G protein signaling modulator 3) Enables GTPase activator activity and small GTPase binding activity. Involved in several processes, including Rap protein signal transduction; positive regulation of GTPase activity; and regulation of Rab protein signal transduction. Located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]
SGSM3-AS1 (HGNC:41088): (SGSM3 antisense RNA 1)
ADSL (HGNC:291): (adenylosuccinate lyase) The protein encoded by this gene belongs to the lyase 1 family. It is an essential enzyme involved in purine metabolism, and catalyzes two non-sequential reactions in the de novo purine biosynthetic pathway: the conversion of succinylaminoimidazole carboxamide ribotide (SAICAR) to aminoimidazole carboxamide ribotide (AICAR) and the conversion of adenylosuccinate (S-AMP) to adenosine monophosphate (AMP). Mutations in this gene are associated with adenylosuccinase deficiency (ADSLD), a disorder marked with psychomotor retardation, epilepsy or autistic features. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.324 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SGSM3NM_015705.6 linkuse as main transcriptc.-112+11539A>C intron_variant ENST00000248929.14

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SGSM3ENST00000248929.14 linkuse as main transcriptc.-112+11539A>C intron_variant 1 NM_015705.6 P1Q96HU1-1
SGSM3-AS1ENST00000414261.1 linkuse as main transcriptn.146+5918T>G intron_variant, non_coding_transcript_variant 3

Frequencies

GnomAD3 genomes
AF:
0.126
AC:
19177
AN:
152058
Hom.:
2012
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0293
Gnomad AMI
AF:
0.237
Gnomad AMR
AF:
0.331
Gnomad ASJ
AF:
0.0721
Gnomad EAS
AF:
0.209
Gnomad SAS
AF:
0.127
Gnomad FIN
AF:
0.203
Gnomad MID
AF:
0.0538
Gnomad NFE
AF:
0.123
Gnomad OTH
AF:
0.119
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.126
AC:
19191
AN:
152176
Hom.:
2018
Cov.:
32
AF XY:
0.135
AC XY:
10013
AN XY:
74388
show subpopulations
Gnomad4 AFR
AF:
0.0292
Gnomad4 AMR
AF:
0.332
Gnomad4 ASJ
AF:
0.0721
Gnomad4 EAS
AF:
0.209
Gnomad4 SAS
AF:
0.126
Gnomad4 FIN
AF:
0.203
Gnomad4 NFE
AF:
0.123
Gnomad4 OTH
AF:
0.117
Alfa
AF:
0.129
Hom.:
2624
Bravo
AF:
0.137

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
Cadd
Benign
3.3
Dann
Benign
0.68

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs17001868; hg19: chr22-40778231; API